http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010111667-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3f14575d0ba7180a1371b14fff340d5 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2009-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3396d5e6f8358d4cec34114cf5f31e30 |
| publicationDate | 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010111667-A |
| titleOfInvention | Pharmaceutical composition for antitussive and / or expectorant containing fexofenadine or ebastine |
| abstract | The present invention provides a novel pharmaceutical composition having an excellent inhibitory effect on airway goblet cell hyperplasia, in particular, a pharmaceutical composition useful for the prevention or treatment of respiratory diseases and the like, and further the prevention or treatment of colds and the like. [MEANS FOR SOLVING PROBLEMS] The present inventors have found that fexofenadine or a salt thereof or ebastine, which is an antiallergic agent, has an excellent airway goblet cell hyperplasia inhibitory action, and has solved the above problems. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013119540-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013075892-A |
| priorityDate | 2008-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.